AUG 5, 2026 · PHASE 3 TRIAL
A Study of Lumateperone Versus Placebo in Participants With Major Depressive Disorder
ClinicalTrials.gov
This is an unstarted Phase 3 registration with no results posted; it describes a planned trial design and primary outcome measure only.
Reported
Planned sample size585
Primary outcome measureChange from baseline in Montgomery-Asberg D…
Primary outcome timepointWeek 6